HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nanotech penetration study draws ire

This article was originally published in The Rose Sheet

Executive Summary

A study published in the August journal Nano Letters on the ability of nano-sized particles to permeate skin has drawn criticism from the Nanotechnology Industries Association. The article, "In Vivo Skin Penetration of Quantum Dot Nanoparticles in the Murine Model: The Effect of UVR" measured the effect that UV radiation may have on the ability of nano-sized quantum dots to permeate skin in a mouse model. The researchers found "qualitatively higher" levels of quantum dot penetration in UV-exposed mice, according to the UK trade association. In a Sept. 16 release, NIA maintained the results cannot be interpreted as applying to sunscreens that utilize nano-sized titanium oxide and zinc oxide, which are used as UV filters in sunscreens. NIA contends that the behavior of quantum dots in the skin is not comparable to that of nano-sized sunscreen ingredients, as nanoparticles group together in the skin and form larger particles. In addition, the mouse skin model used in the study is not sufficient for drawing comparisons with sunscreen use in humans," NIA says

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015676

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel